Trevi Therapeutics (TRVI) Debt Ratio (2020 - 2023)

Trevi Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.06 for Q1 2023.

• In Q1 2023, Debt Ratio fell 86.08% year-over-year to 0.06; the TTM figure through Mar 2023 stood at 0.06 (down 86.08% YoY), while the FY2022 annual figure was 0.07, down 80.24% from the prior year.
• Debt Ratio for Q1 2023 stood at 0.06, down from 0.07 in the prior quarter.
• The five-year high for Debt Ratio was 0.46 in Q1 2022, with the low at 0.06 in Q1 2023.
• The 4-year median for Debt Ratio is 0.3 (2020), against an average of 0.26.
• The sharpest annual moves came in 2021 and 2023: Debt Ratio jumped 83.65% in 2021, then plunged 86.08% in 2023.
• Trevi Therapeutics' Debt Ratio stood at 0.3 in 2020, then climbed by 27.16% to 0.38 in 2021, then slumped by 80.24% to 0.07 in 2022, then slipped by 13.45% to 0.06 in 2023.
• Business Quant data shows TRVI's Debt Ratio at 0.06 in Q1 2023, 0.07 in Q4 2022, and 0.08 in Q3 2022.